ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Royal Children's Hospital · The University of Melbourne · +21 more institutions
Abstract
The International League Against Epilepsy (ILAE) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms following the major scientific advances that have taken place since the last ratified classification in 1989. As a critical tool for the practicing clinician, epilepsy classification must be relevant and dynamic to changes in thinking, yet robust and translatable to all areas of the globe. Its primary purpose is for diagnosis of patients, but it is also critical for epilepsy research, development of antiepileptic therapies, and communication around the world. The new classification originates from a draft document submitted for…
Citation impact
- FWCI
- 238.64
- Percentile
- 100%
- References
- 60
Authors
16- IEIngrid E. SchefferCorresponding
Royal Children's Hospital, The University of Melbourne, Florey Institute of Neuroscience and Mental Health, Austin Health
- SFSamuel F. Berkovic
The University of Melbourne, Austin Health
- GCGiuseppe Capovilla
Azienda Ospedaliera Carlo Poma
- MCMary Connolly
University of British Columbia, BC Children's Hospital
- JAJacqueline A. French
New York University
Topics & keywords
- Epilepsy
- Terminology
- Etiology
- Medicine
- Epilepsy syndromes
- Generalized epilepsy
- Pediatrics
- Intensive care medicine
Funding
- UDU.S. Department of DefenseAwards: W81XWH-13-1-0180, W81XWH, W81XWH‐13‐1‐0180, W81XWH-13
- MOMarch of Dimes Foundation
- CCCURE Childhood Cancer
- CUCitizens United for Research in Epilepsy
- PPfizer
- GGlaxoSmithKline
- NNovartis
- SSanofi
- TPTakeda Pharmaceuticals U.S.A.
- SSunovion
- VPVertex Pharmaceuticals
- DSDravet Syndrome UK
- ZZogenix
- UPUltragenyx Pharmaceutical
- AFAlva Foundation
- GPGW Pharmaceuticals
- ATAcorda Therapeutics
- STSage Therapeutics
- ZPZynerba Pharmaceuticals
- SPSupernus Pharmaceuticals
- MMylan
- NNeuroPace
- UUpsher-Smith
- EREpilepsy Research UK
- LLundbeckfonden
- EEisai
- SLStockholms Läns Landsting
- FBFundação Bial
- UCUniversidade Católica de Brasília
- YCYorkhill Children’s Charity
- HLH. Lundbeck A/S
- SPSun Pharma
- EEpilepsiatutkimussäätiö
- NINational Institutes of HealthAwards: 1U54NS100064, 1U54NS100064‐01, W81XWH, 1‐RO1‐NS43209, NS43209
- HRHumanities Research Center, Rice University
- UOUniversity of California, Los Angeles
- CICanadian Institutes of Health Research
- MRMedical Research Council
- NHNational Health and Medical Research Council
- NINational Institute of Neurological Disorders and Stroke
- UPUCB Pharma
- DODivision of Arctic Sciences
- CCilag